全文获取类型
收费全文 | 5876篇 |
免费 | 421篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 77篇 |
儿科学 | 188篇 |
妇产科学 | 136篇 |
基础医学 | 816篇 |
口腔科学 | 93篇 |
临床医学 | 564篇 |
内科学 | 1299篇 |
皮肤病学 | 139篇 |
神经病学 | 362篇 |
特种医学 | 147篇 |
外科学 | 829篇 |
综合类 | 158篇 |
预防医学 | 592篇 |
眼科学 | 123篇 |
药学 | 453篇 |
中国医学 | 25篇 |
肿瘤学 | 344篇 |
出版年
2023年 | 43篇 |
2022年 | 56篇 |
2021年 | 140篇 |
2020年 | 85篇 |
2019年 | 134篇 |
2018年 | 126篇 |
2017年 | 127篇 |
2016年 | 120篇 |
2015年 | 173篇 |
2014年 | 206篇 |
2013年 | 239篇 |
2012年 | 385篇 |
2011年 | 400篇 |
2010年 | 210篇 |
2009年 | 216篇 |
2008年 | 402篇 |
2007年 | 429篇 |
2006年 | 372篇 |
2005年 | 326篇 |
2004年 | 350篇 |
2003年 | 306篇 |
2002年 | 269篇 |
2001年 | 132篇 |
2000年 | 154篇 |
1999年 | 128篇 |
1998年 | 50篇 |
1997年 | 29篇 |
1996年 | 28篇 |
1995年 | 17篇 |
1994年 | 27篇 |
1993年 | 22篇 |
1992年 | 64篇 |
1991年 | 51篇 |
1990年 | 63篇 |
1989年 | 52篇 |
1988年 | 40篇 |
1987年 | 49篇 |
1986年 | 48篇 |
1985年 | 33篇 |
1984年 | 19篇 |
1983年 | 15篇 |
1982年 | 19篇 |
1981年 | 16篇 |
1979年 | 27篇 |
1978年 | 18篇 |
1976年 | 13篇 |
1975年 | 13篇 |
1974年 | 13篇 |
1973年 | 17篇 |
1972年 | 12篇 |
排序方式: 共有6345条查询结果,搜索用时 15 毫秒
81.
82.
83.
Michelle Y L Tang Patrick H Y Chung Hau Y Chan Paul K H Tam Kenneth KY Wong 《Journal of pediatric surgery》2019,54(2):255-257
Objective
Helicobacter pylori infection is common among Asians. However, evidence in the recent years has demonstrated a decrease in the prevalence of H. pylori infection among children and adults worldwide. Our aim was to update its prevalence in symptomatic children in our locality in the recent 12?years and compared to the results of our previous review published in 2005.Methods
A retrospective review was carried out between 2005 and 2017. All children who presented with dyspepsia or gastrointestinal bleeding and underwent oesophagogastroduodenoscopy with antral biopsy taken were included. Patient demographics, endoscopic, or histological diagnosis and the H. pylori status were recorded.Main Results
A total of 602 patients were included. There was a statistically significant decreasing trend of H. pylori infection rate between 2005 and 2017 (p?=?0.003). The overall infection rate from this study was 12.8%, compared to 25.6% from our previous review. Overall failure of eradication with first-line antibiotic therapy has increased to 29.3% from 10% in our previous review.Conclusion
There was a decrease in the prevalence of H. pylori infection among symptomatic children for the recent 12?years, comparing to our previous data from 2005. We hypothesize that the reduction in prevalence of H. pylori infection among adults and the decrease in the practice of sharing chopsticks during meals have led to a decrease in transmission of the bacteria among family members in Hong Kong. However, the failure of eradication with first line treatment was higher, possibly due to the increase in antibiotics usage and resistance.Level of Evidence
III 相似文献84.
85.
86.
87.
Three‐dimensional speckle tracking echocardiography–derived left atrial deformation analysis in acromegaly (Results from the MAGYAR‐Path Study) 下载免费PDF全文
88.
Kwok-Chiu Chang Wing-Wai Yew Cheuk-Ming Tam Chi-Chiu Leung 《Antimicrobial agents and chemotherapy》2013,57(9):4097-4104
It is often necessary to include WHO group 5 drugs in the treatment of extensively drug-resistant tuberculosis (XDR-TB) and fluoroquinolone-resistant multidrug-resistant tuberculosis (MDR-TB). As clinical evidence about the use of group 5 drugs is scarce, we conducted a systematic review using published individual patient data. We searched PubMed and OvidSP through 7 April 2013 for publications in English to assemble a cohort with fluoroquinolone-resistant MDR-TB treated with group 5 drugs. Favorable outcome was defined as sputum culture conversion, cure, or treatment completion in the absence of death, default, treatment failure, or relapse. A cohort of 194 patients was assembled from 20 articles involving 12 geographical regions. In descending order of frequency, linezolid was used in treatment of 162 (84%) patients, macrolides in 84 (43%), clofazimine in 65 (34%), amoxicillin with clavulanate in 56 (29%), thioridazine in 18 (9%), carbapenem in 16 (8%), and high-dose isoniazid in 16 (8%). Cohort analysis with robust Poisson regression models and random-effects meta-analysis similarly suggested that linezolid use significantly increased the probability (95% confidence interval) of favorable outcome by 57% (10% to 124%) and 55% (10% to 121%), respectively. Defining significant associations by risk ratios ≥ 1.2 or ≤ 0.9, neither cohort analysis nor meta-analysis demonstrated any significant add-on benefit from the use of other group 5 drugs with respect to outcome for patients treated with linezolid, although selection bias might have led to underestimation of their effects. Our findings substantiated the use of linezolid in the treatment of XDR-TB or fluoroquinolone-resistant MDR-TB and call for further studies to evaluate the roles of other group 5 drugs. 相似文献
89.
90.